KZE has prepared a broad array of medical communication products in support of drugs developed for the treatment of viral and bacterial infections.
Medical Writing Products
Peer reviewed clinical trial-based manuscripts
Publication team management for products in development for treating influenza, herpes simplex, sinusitis, and chronic bronchitis.
Publication planning for a recombinant tissue factor pathway inhibitor in treating sepsis.
Bibliography: Sample Publications and Abstracts
Routy JP, Boulassel MR, Yassine-Diab B, et al. Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. Clin Imunol, 134(2):140-7, 2010.
SL Spruance and J Hill . Clinical significance of antiviral therapy for episodic treatment of herpes labialis: exploratory analyses of the combined data from two valacyclovir trials. J Antimicrob Chemother 53(5):703-7, 2004.
SL Spruance , TM Jones, MM Blatter et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob Agents Chemother 47(3):1072-80, 2003.
A Peng, S Milleri, DS Stein. Direct measurement of the anti-influenza compound zanamivir in the respiratory tract following inhaled administration. Antimic Agents Chemother, 44: 1974-76, 2000
A Peng, EK Hussey, KHP Moore. A population pharmacokinetic analysis of zanamivir in subjects with experimental and naturally occurring influenza J Clin Pharm, 40:242-49, 1999
DA Baker, JG Blythe, JM Miller. Once-daily valacyclovir for suppression of recurrent genital herpes. Obstet Gynecol, 93 103-6, 1999.
VM Vogt, DA Bruckenstein and AP Bell. Avian Sarcoma virus “gag” precursor polypeptide is not processed in mammalian cells. J. Virology, 44:725-730, 1982.